Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Techniques & Tools

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma & Biopharma
    • Omics
    • Forensics
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Power List / 2022

The Power List 2022

We asked you to nominate the influential people making the most impact in the drug-making space – and we listened. Now, we invite you to join us as we celebrate the top 10 leaders in small molecules, biopharmaceuticals, and advanced therapy – 30 amazing individuals in total.

Small Molecules

John Chiminski
John Chiminski

Chair and CEO, Catalent Pharma Solutions

Kevin Cook
Kevin Cook

Chair and CEO, Sterling Pharma Solutions

Patrick Couvreur
Patrick Couvreur

Emeritus Professor of Pharmacy, Paris-Saclay University, France

Cheng Fang
Cheng Fang

Senior Vice President of Research & Development, Annovis Bio

Rebecca Guntern
Rebecca Guntern

Head of Europe, Sandoz

Edward Haeggström
Edward Haeggström

CEO, Nanoform

Johannes Khinast
Johannes Khinast

Professor of Pharmaceutical Engineering, Graz University of Technology, and CEO of RCPE

Nigel Langley
Nigel Langley

Global Technology Director, BASF

Claire Thompson
Claire Thompson

CEO, Life Agility Sciences

Martin VanTrieste
Martin VanTrieste

President and Chief Executive Officer at Civica Rx

Biopharmaceuticals

Rick Bright
Rick Bright

CEO, Pandemic Prevention Institute, The Rockefeller Foundation

Eric Dube
Eric Dube

President, CEO, and Director, Travere Therapeutics

Micki Hultquist
Micki Hultquist

Global Franchise Head, AstraZeneca

Sabrina Martucci Johnson
Sabrina Martucci Johnson

President, CEO, and a member of the board at Daré Bioscience

Maik Jornitz
Maik Jornitz

President and CEO, G-CON Manufacturing

Gurutz Linazasoro
Gurutz Linazasoro

Chief Executive Officer, VIVEbiotech

Hanns-Christian Mahler
Hanns-Christian Mahler

Chief Enablement Officer (CEO) and Board Member, ten23 health AG, Basel, Switzerland

John V. Oyler
John V. Oyler

Co-Founder and Chairman, BeiGene

Mike Rea
Mike Rea

CEO and Founder, IDEA Pharma and Protodigm

Jan van de Winkel
Jan van de Winkel

President and CEO at Genmab

Advanced Medicine

Massimo Dominici
Massimo Dominici

Oncology Professor, University Hospital of Modena and Reggio Emilia and Scientific Founder, Rigenerand

Miguel Forte
Miguel Forte

Chief Executive Officer, Bone Therapeutics, and Professor, Lisbon University

Jacques Galipeau
Jacques Galipeau

Don and Marilyn Anderson Professor of Oncology and Associate Dean for Therapeutics Development, University of Wisconsin in Madison, US

Fabian Gerlinghaus
Fabian Gerlinghaus

Co-Founder and Chief Executive Officer, Cellares

Queenie Jang
Queenie Jang

Chief Executive Officer, International Society for Cell & Gene Therapy

David Kirn
David Kirn

Co-Founder & Chief Executive Officer, 4D Molecular Therapeutics

Bruce Levine
Bruce Levine

Barbara and Edward Netter Professor in Cancer Gene Therapy at the University of Pennsylvania

Marianthi Psaha
Marianthi Psaha

Global Head Cell & Gene Therapy, Santen Pharmaceutical

Chris van der Walle
Chris van der Walle

Edinburgh Centre Director, Cell & Gene Therapy Catapult

Paul K. Wotton
Paul K. Wotton

CEO, Obsidian

False

Advertisement

Recommended

False

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.